NO20006652L - Fremgangsmåte til å behandle pulmonal hypertensjon - Google Patents

Fremgangsmåte til å behandle pulmonal hypertensjon

Info

Publication number
NO20006652L
NO20006652L NO20006652A NO20006652A NO20006652L NO 20006652 L NO20006652 L NO 20006652L NO 20006652 A NO20006652 A NO 20006652A NO 20006652 A NO20006652 A NO 20006652A NO 20006652 L NO20006652 L NO 20006652L
Authority
NO
Norway
Prior art keywords
pulmonary hypertension
treating pulmonary
treatment
levosimendan
propanedinitrile
Prior art date
Application number
NO20006652A
Other languages
English (en)
Other versions
NO317593B1 (no
NO20006652D0 (no
Inventor
Lasse Lehtonen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20006652L publication Critical patent/NO20006652L/no
Publication of NO20006652D0 publication Critical patent/NO20006652D0/no
Publication of NO317593B1 publication Critical patent/NO317593B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO20006652A 1998-06-25 2000-12-22 Fremgangsmate til a behandle pulmonal hypertensjon NO317593B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981473A FI981473L (fi) 1998-06-25 1998-06-25 Menetelmä pulmonaalihypertension hoitamiseksi
PCT/FI1999/000540 WO1999066912A2 (en) 1998-06-25 1999-06-18 Method of treating pulmonary hypertension

Publications (3)

Publication Number Publication Date
NO20006652L true NO20006652L (no) 2000-12-22
NO20006652D0 NO20006652D0 (no) 2000-12-22
NO317593B1 NO317593B1 (no) 2004-11-15

Family

ID=8552079

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006652A NO317593B1 (no) 1998-06-25 2000-12-22 Fremgangsmate til a behandle pulmonal hypertensjon

Country Status (24)

Country Link
US (1) US6462045B1 (no)
EP (1) EP1089737B1 (no)
JP (1) JP4536922B2 (no)
KR (1) KR100661769B1 (no)
AT (1) ATE226076T1 (no)
AU (1) AU748883B2 (no)
BR (1) BR9911422A (no)
CA (1) CA2335280C (no)
CZ (1) CZ300844B6 (no)
DE (1) DE69903546T2 (no)
DK (1) DK1089737T3 (no)
EA (1) EA003055B1 (no)
EE (1) EE04355B1 (no)
ES (1) ES2186375T3 (no)
FI (1) FI981473L (no)
HU (1) HU226021B1 (no)
MX (1) MXPA00012618A (no)
NO (1) NO317593B1 (no)
NZ (1) NZ508833A (no)
PL (1) PL193055B1 (no)
PT (1) PT1089737E (no)
SK (1) SK284581B6 (no)
WO (1) WO1999066912A2 (no)
ZA (1) ZA200007462B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20001542L (fi) * 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
FI20010233A0 (fi) 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20040675A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä sydämen hypertrofian hoitoon ja estoon
US20070010518A1 (en) * 2005-02-18 2007-01-11 Matti Kivikko Method for administering levosimendan
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
CZ285129B6 (cs) * 1991-04-17 1999-05-12 Merck & Co., Inc. Oftalmické přípravky, obsahující kombinace inhibitoru karboanhydrasy a beta-adrenergního antagonisty
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
PT1089737E (pt) 2003-03-31
EE200000775A (et) 2002-04-15
KR100661769B1 (ko) 2006-12-28
SK19252000A3 (sk) 2002-04-04
EA003055B1 (ru) 2002-12-26
AU748883B2 (en) 2002-06-13
BR9911422A (pt) 2001-03-13
JP2002518436A (ja) 2002-06-25
ZA200007462B (en) 2002-03-13
FI981473A0 (fi) 1998-06-25
NO317593B1 (no) 2004-11-15
NO20006652D0 (no) 2000-12-22
MXPA00012618A (es) 2005-06-06
HUP0102929A2 (hu) 2002-04-29
KR20010072640A (ko) 2001-07-31
ATE226076T1 (de) 2002-11-15
US6462045B1 (en) 2002-10-08
DE69903546T2 (de) 2003-06-18
PL193055B1 (pl) 2007-01-31
DE69903546D1 (de) 2002-11-21
NZ508833A (en) 2002-10-25
CZ300844B6 (cs) 2009-08-26
CZ20004663A3 (en) 2001-05-16
HUP0102929A3 (en) 2002-07-29
JP4536922B2 (ja) 2010-09-01
ES2186375T3 (es) 2003-05-01
CA2335280C (en) 2007-10-30
WO1999066912A3 (en) 2000-03-16
FI981473A7 (fi) 1999-12-26
WO1999066912A2 (en) 1999-12-29
AU4786499A (en) 2000-01-10
EE04355B1 (et) 2004-10-15
FI981473L (fi) 1999-12-26
DK1089737T3 (da) 2003-02-10
EP1089737A2 (en) 2001-04-11
PL345467A1 (en) 2001-12-17
EP1089737B1 (en) 2002-10-16
SK284581B6 (sk) 2005-07-01
HU226021B1 (en) 2008-03-28
EA200100074A1 (ru) 2001-06-25
CA2335280A1 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
YU48767B (sh) (-)-[[4-(1,4,5,6-tetrahidro-4-metil-6-okso-3-piridazinil)fenil]hidrazono]propandinitril, postupak za njegovo dobijanje i intermedijeri
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
CA2134972A1 (en) Anti-ischemic medicament
NO20006652D0 (no) Fremgangsmåte til å behandle pulmonal hypertensjon
NO308897B1 (no) Benzotiazin-dioksyder som endotelin-antagonister, fremgangsmÕter for fremstilling derav, farmasøytiske preparater omfattende forbindelsene, samt anvendelse av forbindelsene
ATE525361T1 (de) Verfahren zum erhalt von reinen enantiomeren eines pyridazinonderivats
NO20016316L (no) Fremgangsmåte til å behandle eller forhindre kransarterietransplantasjonsvasospasme
EA200001098A1 (ru) Пероральные композиции с контролируемым высвобождением левозимендана
DE69915475D1 (de) Verwendung einer pyridazinonverbindung als calcium sensibilisator
FI20001542A7 (fi) Menetelmä septisen sokin hoitamiseksi
DE60016038D1 (de) Neue verwendung von levosimendan
WO2002047603A3 (en) Use of levosimendan for treating erictile dysfunction

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees